development, cell therapy, and synthetic biology. The company also offers a range of assay kits, such as Cyto-Cellect® products, to detect cell productivity and viability for human and mouse antibodies, as well as Fc fusion proteins. Sphere Bio’s solutions integrate seamlessly into laboratory workflows, allowing researchers to analyze millions of cells efficiently without compromising viability. Its technology is built around stable, biocompatible picodroplets that encapsulate individual cells for large-scale single-cell experiments.